Rekawan® film-coated tablets 1000 mg are available again

Berlin, 05 Mai 2020 – RIEMSER Pharma GmbH, part of the global pharmaceutical company, Esteve Healthcare, is pleased to announce that Rekawan® film-coated tablets 1000 mg are available once again with immediate effect. The potassium supplement is available from pharmacies without prescription and in pack sizes of 50 and 100 tablets.

Rekawan® film-coated tablets 1000 mg are used for potassium substitution in cases of severe potassium deficiency (hypokalaemia), in particular with concomitant metabolic alkalosis.


About Rekawan®

Rekawan® is a pharmacy-only, over-the-counter medicinal product for the treatment of potassium deficiency (hypokalaemia) in the blood. It is used for potassium substitution in cases of severe hypokalaemia (serum potassium below 3.2 mmol/l), in particular with concomitant metabolic alkalosis


About RIEMSER

RIEMSER Pharma GmbH (www.riemser.com) is part of Esteve Healthcare (ESTEVE, www.esteve.com), a global pharmaceutical corporation based in Barcelona. Established in 1992, RIEMSER purchases, licenses, markets and distributes pharmaceutical products. RIEMSER has over 440 approvals worldwide, 46 of which have been newly granted in the last three years, demonstrating the company’s specific expertise in the approval and opening of new markets for pharmaceutical products.

The company’s product range includes prescription drugs used to treat serious diseases, mainly in the therapeutic areas of oncology, infectious diseases, neurology and dermatology.

RIEMSER has three sites in Germany, including a manufacturing plant, and it manages an international distribution network. It also has two subsidiaries in France and the UK.

You can find more information at www.riemser.com.

 

Press Contact

 

RIEMSER Pharma GmbH
Dr. Marlies Michaelis
michaelis[at]riemser[dot]com
Tel: +49 30 338427- 405

pressestelle[at]riemser[dot]com
Tel: +49 30 338427-100

___________________________

 

Required information pursuant to Section 4 of the HWG (Act governing the advertisement of therapeutic products)

Name of the medicinal product
: Rekawan® film-coated tablets 1000 mg
Active ingredient: 1 tablet with modified active substance release contains 1000 mg potassium chloride (= 13.4 mmol potassium).
Areas of application:
Rekawan®  film-coated tablets 1000 mg are a potassium supplement. They are used for potassium substitution in cases of severe potassium deficiency (blood potassium levels below 3.2 mmol/I), in particular with concomitant metabolic alkalosis (reduced acidity of the blood).
Last updated: June 2016
Marketing Authorisation Holder: RIEMSER Pharma GmbH, An der Wiek 7, D-17493 Greifswald – Insel Riems, Germany
“Please refer to the package leaflet or consult your doctor or pharmacist for information about risks and side effects.”